DDP
DDP is a pharmaceutical drug with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
7
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Platinum Rechallenge in Patients With Platinum-sensitive mTNBC
Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma
Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.
Clinical Trials (10)
Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Platinum Rechallenge in Patients With Platinum-sensitive mTNBC
Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma
Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.
A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer
Assessment of Cost-effectiveness in Two Empirically-based Psychotherapies for Borderline Personality Disorder: A Randomized Controlled Trial
PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer
Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10